Productive replication of human adenoviruses in mouse epidermal cells

Journal of Virology

Volumn 74, Issue 6, 2000, Pages 2895-2899

  Ganly, Ian ^b   Mautner, Vivien ^c   Balmain, Allan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; EPIDERMIS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

3T3 CELLS; ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; ANIMALS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; EPIDERMIS; HUMANS; MICE; TUMOR CELLS, CULTURED; VINCULIN; VIRUS REPLICATION;

EID: 0033993462     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.6.2895-2899.2000     Document Type: Article

References (23)

1. Aneskievich, B. J., J. I. Lee, and L. B. Taichman. 1990. Analysis of adenovirus early and late gene expression in cultured epidermal keratinocytes. Differentiation 94:183-186.
2. Bischoff, J. R., D. H. Kim, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
3. Burns, P. A., C. J. Kemp, J. V. Gannon, D. P. Lane, R. Bremner, and A. Balmain. 1991. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene 6:2363-2369.
4. Duncan, S. J., F. C. Gordon, D. W. Gregory, J. L. McPhie, R. Postlethwaite, R. White, and H. N. Willcox. 1978. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40:45-61.
5. Eggerding, F. A., and W. C. Pierce. 1986. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 148:97-113.
6. Esandi, M. C., G. D. van Someren, A. J. Vincent, D. W. van Bekkum, D. Valerio, A. Bout, and J. L. Noteboom. 1997. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther. 4:280-287.
7. Fognani, C., V. G. Della, and L. E. Babiss. 1993. Repression of adenovirus E1A enhancer activity by a novel zinc finger-containing DNA-binding protein related to the GLI-Kruppel protein. EMBO J 12:4985-4992.
8. Ginsberg, H. S. 1996. The ups and downs of adenovirus vectors. Bull. N. Y. Acad. Med. 73:53-58.
9. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
10. Graham, F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors, p. 109-128. In Methods in molecular biology, vol. 7. Humana Press, Clifton, N.J.
11. Heise, C., A. Sampson-Johannes, A. Williams, F. McCormick, D. D. Von Hoff, and D. H. Kirn. 1997. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:639-645.
12. Kelly, F., and M. Boccara. 1976. Susceptibility of teratocarcinoma cells to adenovirus type 2. Nature 262:409-411.
13. Ko, S. C., A. Gotoh, G. N. Thalmann, H. E. Zhau, D. A. Johnston, W. W. Zhang, C. Kao, and L. W. Chung. 1996. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum. Gene Ther. 7:1683-1691.
14. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215-219. (Erratum, 91:1979, 1994.)
15. Laporta, R. F., and L. B. Taichman. 1981. Adenovirus type-2 infection of human keratinocytes: viral expression dependent upon the state of cellular maturation. Virology 110:137-146.
16. Lucher, L. A. 1995. Abortive adenovirus infection and host range determinants, p. 119-152. In W. Doerfler and P. Bohm (ed.), The molecular repertoire of adenoviruses I. Springer Verlag, Berlin, Germany.
17. Oualikene, W., P. Gonin, and M. Eloit. 1994. Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species. J. Gen. Virol. 75:2765-2768.
18. Pacini, D. L., E. J. Dubovi, and W. A. J. Clyde. 1984. A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150:92-97.
19. Portella, G., S. A. Cumming, J. Liddell, W. Cui, H. Ireland, R. J. Akhurst, and A. Balmain. 1998. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9:393-404.
20. Quillien, V., L. B. Heresbach, T. Dufour, A. Denais, Y. Guegan, N. Ferry, and V. Bloin. 1997. Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene. Bull. Cancer 84:1047-1052.
21. Silverstein, G., and W. A. Strohl. 1986. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch. Virol. 87:241-264.
22. Stoler, A. B., F. Stenback, and A. Balmain. 1993. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol. 122:1103-1117.
23. Wilson, J. M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1185-1187.